Device / Technology News

RSS

St. Luke’s surgeons first to perform percutaneous Mitral Valve Repair using MitraClip technology

Arthur Decheser said the “doctors were dancing” last week after they successfully used a new device to stop his mitral valve from leaking.

11 Aug 2015

Sorrento, TNK Therapeutics to exclusively license NanoVelcro CTC assay from CytoLumina and FetoLumina

Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.

11 Aug 2015

C.R. Bard agrees to pay over $200 million to settle transvaginal mesh lawsuit claims

MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, reports today that C.R. Bard Inc. has recently settled at least 3,000 cases against them, agreeing to pay more than $200 million to the women plaintiffs who were injured by the company's vaginal-mesh inserts.

11 Aug 2015

New technology advances genome engineering

In his mind, Basil Hubbard can already picture a new world of therapeutic treatments for millions of patients just over the horizon. It's a future in which diseases like muscular dystrophy, cystic fibrosis and many others are treated permanently through the science of genome engineering.

11 Aug 2015

SCCA Proton Therapy Center makes advanced radiation therapy accessible to patients with ocular melanoma

For most the ability to see is often taken for granted. But for the thousands diagnosed with ocular melanoma, the fear of losing their eyesight or even worse, their lives, is an all too real possibility. Ocular melanoma is seen as a rare form of cancer, with approximately two thousand new diagnoses per year.

11 Aug 2015

Researchers create new cell screening method for immunotherapy cancer treatments

Researchers have created a new method for screening cells used in immunotherapy cancer treatments, allowing high-performing immune system cells to be studied in isolation and potentially expanding the number of patients for whom the breakthrough treatment proves successful.

11 Aug 2015

PrediXcan method improves detection of genes linked to complex diseases, biological traits of interest

A new computational method developed by scientists from the University of Chicago improves the detection of genes that are likely to be causal for complex diseases and biological traits. The method, PrediXcan, estimates gene expression levels across the whole genome - a better measure of biological action than single mutations - and integrates it with genome-wide association study (GWAS) data.

11 Aug 2015

Instrumentation Laboratory announces European release of HemosIL Rivaroxaban Testing Solution

Instrumentation Laboratory today announced the commercialization of their HemosIL Rivaroxaban Testing Solution in Europe. The HemosIL Liquid Anti-Xa assay, when used in conjunction with HemosIL Rivaroxaban Calibrators and HemosIL Rivaroxaban controls offers an automated solution for measurement of rivaroxaban.

10 Aug 2015

Intrexon, Synthetic Biologics form ECC to develop and commercialize novel biotherapeutics for phenylketonuria

Intrexon Corporation, a leader in synthetic biology, and Synthetic Biologics, Inc., a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, today announced an Exclusive Channel Collaboration (ECC) to pursue the development and commercialization of novel biotherapeutics for the treatment of patients with phenylketonuria (PKU), a serious and debilitating metabolic disorder.

10 Aug 2015

TNK Therapeutics acquires multiple preclinical and clinical stage CAR-T immunotherapy programs

Sorrento Therapeutics, Inc. announced today that its wholly-owned subsidiary, TNK Therapeutics, Inc., has acquired multiple preclinical and clinical stage chimeric antigen receptor (CAR)-T immunotherapy programs as well as underlying CAR-T technology through the acquisition of two privately-held biotechnology companies.

10 Aug 2015

BioClinica announces launch of eHealth Cloud platform

BioClinica, Inc., a specialty clinical trials services and technology provider, today announced the launch of the BioClinica eHealth Cloud, a flexible and highly configurable platform offering that extends beyond the scope of traditional clinical trial technology approaches.

From Clario 10 Aug 2015

Sheffield researchers win national awards for pioneering work on coeliac disease, IBS

Researchers at Sheffield Teaching Hospitals have received awards for their work investigating coeliac disease and irritable bowel syndrome, two common gastrointestinal conditions.

10 Aug 2015

Laser eye surgery: a glimpse into the future - An interview with Professor Dan Reinstein

LASIK (Laser In Situ Keratomileusis) creates a hinged flap with a microkeratome and evaporating corneal tissue under the flap with an excimer laser. However, the concept that refractive error could be corrected by sculpting corneal stromal tissue to change corneal curvature was the brainchild of Jose Ignacio Barraquer Moner in 1948.

9 Aug 2015

Flowonix Medical's new Patient Therapy Controller approved for market release

Flowonix Medical, Inc., announced today that its newest product, the Patient Therapy Controller (PTC), has been approved for market release. The PTC interfaces with the company's Prometra platform of intrathecal infusion devices. A small, hand-held device with a touch-screen, the PTC allows the patient to initiate a bolus delivery of medication from the implanted pump.

7 Aug 2015

St. Luke’s neurosurgeon partners with Medtronic to perform first live feed neurosurgery

St. Luke’s University Health Network’s functional neurosurgeon Steven Falowski, MD, has partnered with Medtronic medical device company to promote faster and better product development within the field of neuromodulation for patients with pain and disability related to nerve disorders.

7 Aug 2015

Brili launches new app for families with ADHD kids at 2015 APA Convention

Brili Inc., the company that creates technology to help kids succeed, today launches an app for families challenged with ADHD at the 2015 APA Convention. The conference will feature over thirty different presentations focused on ADHD, indicative of the pervasiveness of a condition affecting millions of children. Brili will be showcasing how their app can help families manage the challenges of ADHD during the hectic and challenging back to school crunch.

7 Aug 2015

New technology that tracks patients' eye movements may accurately measure brain injury

New technology that tracks the eye movements of patients may be a more accurate measure of brain injury than any other diagnostic measurements currently in use, according to a study recently published in the journal Concussion.

7 Aug 2015

First self-assessment test developed to help clinicians diagnose autism in adults

Psychologists from Cardiff University have developed the first self-assessment test designed to help clinicians diagnose autism in adults.

7 Aug 2015

Scientists develop biosensor to measure abnormal activity of cell 'fuel' carrier

To be able to function, cell mitochondria import "fuel" using a carrier, the Mitochondrial Pyruvate Carrier (MPC). In order to determine whether the MPC is still functional in malignant cells, the team of Professor Jean-Claude Martinou, at the University of Geneva, Switzerland, has just developed a biosensor to measure its live activity.

7 Aug 2015

Researchers develop new technology to track DNA-protein binding in live cells

Researchers have developed a new technology that precisely marks where groups of regulatory proteins called transcription factors bind DNA in the nuclei of live cells.

7 Aug 2015

Device / Technology News

St. Luke’s surgeons first to perform percutaneous Mitral Valve Repair using MitraClip technology

Sorrento, TNK Therapeutics to exclusively license NanoVelcro CTC assay from CytoLumina and FetoLumina

C.R. Bard agrees to pay over $200 million to settle transvaginal mesh lawsuit claims

New technology advances genome engineering

SCCA Proton Therapy Center makes advanced radiation therapy accessible to patients with ocular melanoma

Researchers create new cell screening method for immunotherapy cancer treatments

PrediXcan method improves detection of genes linked to complex diseases, biological traits of interest

Instrumentation Laboratory announces European release of HemosIL Rivaroxaban Testing Solution

Intrexon, Synthetic Biologics form ECC to develop and commercialize novel biotherapeutics for phenylketonuria

TNK Therapeutics acquires multiple preclinical and clinical stage CAR-T immunotherapy programs

BioClinica announces launch of eHealth Cloud platform

Sheffield researchers win national awards for pioneering work on coeliac disease, IBS

Laser eye surgery: a glimpse into the future - An interview with Professor Dan Reinstein

Flowonix Medical's new Patient Therapy Controller approved for market release

St. Luke’s neurosurgeon partners with Medtronic to perform first live feed neurosurgery

Brili launches new app for families with ADHD kids at 2015 APA Convention

New technology that tracks patients' eye movements may accurately measure brain injury

First self-assessment test developed to help clinicians diagnose autism in adults

Scientists develop biosensor to measure abnormal activity of cell 'fuel' carrier

Researchers develop new technology to track DNA-protein binding in live cells

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News